Skip to content

Sexual Health Integration in Treatment of Gynecological Oncology

Integrating Mandatory Sexual Health Counseling in Gynaecological Oncology: A Paradigm Shift From Diagnosis to Survivorship.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06958068
Acronym
SHIFT-GO
Enrollment
324
Registered
2025-05-06
Start date
2022-01-01
Completion date
2025-04-25
Last updated
2025-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancers, Endometrial Cancer, Ovarian Cancer, Sexual Counselling, Sexual Health Quality of Life, Vaginal Cancers

Keywords

gynecological cancer, sexual health, sexual counselling, paradigma, sexual activity

Brief summary

The goal of this cross-section observational and questionary based study is to learn how geological cancer survivors perceive sexual health support given by health care professionals during diagnosis and treatment process. The main question to be answered is: Who, when and to what extend should discuss the sexual health issues The participants will answer online survey questions about Sexual health issues and Sexual counselling during diagnosis, treatment and follow-up.

Detailed description

The main aim of the study is to verify who, from medical specialist, should discuss the sexual health issues in gynecological cancer survivors, when that discussion should take places and to what exited all sexual issues should be discusses. The secondary end points are: * to establish factors affecting returning to sexual activities defined as any type of physical contact with a partner engaging sexual organs as well as mutual and solo masturbation. * to verified if gender of counselling specialist is important to patients. The study is a cross-section observation one. It is based on a survey containing questions regarding basic socioeconomical factors, treatment history, reproductive history, and those concerning the opinion who, when, to what extend and how should ask about sexual issues during therapy modalities planning, treatment and follow-up. Women after completing a treatment irrespectively of its type (surgery, radiation, chemotherapy, immune check point inhibitors) will be eligible for the study. Those who are no more sexually active and currently have no sexual partner will also be included. After collecting the date three main analysis will be conducted to answer the study questions. The results will be used as a basic for further work on recommendation on sexual health counselling in gynecological malignancies.

Interventions

None listed

Sponsors

Medical University of Silesia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed with gynecological malignancies except breast cancer * completion of treatment irrespectively of its type (surgery, CTH, RTH, immunotherapy) * ECOG≤2

Exclusion criteria

* diagnosed with breast cancer * currently being treated for gynecological or other malignancies * ECOG \>2 * not being able to have any type of sexual activity due to physical limitations or comorbidities

Design outcomes

Primary

MeasureTime frameDescription
Who should counsel patients with gynecological malignanciesAt least 8 weeks post treatment completionA set of questions were asked to verify the hypothesis that specialist in gynecological oncology should inform about sexual issues during the treatment ant after its completion. Timing, frequency of counselling and patients' preferences for sexual information sources were established.

Secondary

MeasureTime frameDescription
Gender of gynecological oncologist counselling the patientAt least 8 weeks post treatment completionA set of questions were ask to verify the hypothesis that in case of cancer choosing the specialist in gynecological oncology in not gender-based but knowledge and skills-based.
Returning to sexual activity defining as any sexual contact with a partner or solo masturbationAt least 8 weeks post treatment completionA set of question were asked to verify factors that might influence returning to sexual activity after treatment completion

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026